Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Ma

Showing results (41-50 of 357) with videos related to

Pageof 36
Sort By:
Alimentary Pharmacology & Therapeutics|March 21, 2021
Editorial: an expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials-a missing link. Authors' replyVipul Jairath, Ahmed Almradi, Rish K Pai, et al.
Intestinal Research|May 11, 2018
The old versus the new: which do you keep in postoperative Crohn's disease?Paulo Gustavo Kotze, Christopher Ma, Miguel Regueiro, et al.
Therapeutic Advances in Gastroenterology|June 7, 2023
A review of the role of intermittent fasting in the management of inflammatory bowel diseaseCeleste M Lavallee, Andreina Bruno, Christopher Ma, et al.
Nutrients|November 11, 2022
The Role of Intermittent Fasting in the Management of Nonalcoholic Fatty Liver Disease: A Narrative ReviewCeleste M Lavallee, Andreina Bruno, Christopher Ma, et al.
Expert Opinion on Investigational Drugs|July 31, 2018
Investigational drugs in phase I and phase II clinical trials targeting interleukin 23 (IL23) for the treatment of Crohn's diseaseChristopher Ma, Vipul Jairath, Reena Khanna, et al.
Journal of Inflammation Research|February 16, 2018
Clinical utility of ustekinumab in Crohn's diseasePaulo Gustavo Kotze, Christopher Ma, Abdulelah Almutairdi, et al.
Gastroenterology & Hepatology|May 4, 2022
Janus Kinase Inhibitors for the Management of Patients With Inflammatory Bowel DiseaseRocio Sedano, Christopher Ma, Vipul Jairath, et al.
Journal of the American Chemical Society|October 10, 2017
Designer α1,6-Fucosidase Mutants Enable Direct Core Fucosylation of Intact N-Glycopeptides and N-GlycoproteinsChao Li, Shilei Zhu, Christopher Ma, et al.
BMC Genomics|September 3, 2015
An unsupervised learning approach to find ovarian cancer genes through integration of biological dataChristopher Ma, Yixin Chen, Dawn Wilkins, et al.
Current Drug Targets|May 23, 2019
Pre-operative Exposure to Ustekinumab: A Risk Factor for Postoperative Complications in Crohn's Disease (CD)?Hang Hock Shim, Christopher Ma, Paulo Gustavo Kotze, et al.
Pageof 36

Showing results (41-50 of 357) with videos related to

Sort By:
Pageof 36
Alimentary Pharmacology & Therapeutics|March 21, 2021
Editorial: an expert consensus to standardise the assessment of histological disease activity in Crohn's disease clinical trials-a missing link. Authors' replyVipul Jairath, Ahmed Almradi, Rish K Pai, et al.
Intestinal Research|May 11, 2018
The old versus the new: which do you keep in postoperative Crohn's disease?Paulo Gustavo Kotze, Christopher Ma, Miguel Regueiro, et al.
Therapeutic Advances in Gastroenterology|June 7, 2023
A review of the role of intermittent fasting in the management of inflammatory bowel diseaseCeleste M Lavallee, Andreina Bruno, Christopher Ma, et al.
Nutrients|November 11, 2022
The Role of Intermittent Fasting in the Management of Nonalcoholic Fatty Liver Disease: A Narrative ReviewCeleste M Lavallee, Andreina Bruno, Christopher Ma, et al.
Expert Opinion on Investigational Drugs|July 31, 2018
Investigational drugs in phase I and phase II clinical trials targeting interleukin 23 (IL23) for the treatment of Crohn's diseaseChristopher Ma, Vipul Jairath, Reena Khanna, et al.
Journal of Inflammation Research|February 16, 2018
Clinical utility of ustekinumab in Crohn's diseasePaulo Gustavo Kotze, Christopher Ma, Abdulelah Almutairdi, et al.
Gastroenterology & Hepatology|May 4, 2022
Janus Kinase Inhibitors for the Management of Patients With Inflammatory Bowel DiseaseRocio Sedano, Christopher Ma, Vipul Jairath, et al.
Journal of the American Chemical Society|October 10, 2017
Designer α1,6-Fucosidase Mutants Enable Direct Core Fucosylation of Intact N-Glycopeptides and N-GlycoproteinsChao Li, Shilei Zhu, Christopher Ma, et al.
BMC Genomics|September 3, 2015
An unsupervised learning approach to find ovarian cancer genes through integration of biological dataChristopher Ma, Yixin Chen, Dawn Wilkins, et al.
Current Drug Targets|May 23, 2019
Pre-operative Exposure to Ustekinumab: A Risk Factor for Postoperative Complications in Crohn's Disease (CD)?Hang Hock Shim, Christopher Ma, Paulo Gustavo Kotze, et al.
Pageof 36